


| Key | % Net Assets |
|---|---|
| 5.2% | |
| 4.0% | |
| 3.9% | |
| 3.8% | |
| 83.1% |
| Name | % Net Assets |
|---|---|
| Total | 5.2% |
| Nestle | 4.0% |
| Novartis | 3.9% |
| Total | 3.8% |
| Sanofi-Aventis | 3.7% |
| Sanofi-Aventis | 3.5% |
| Vivendi | 3.3% |
| Bayer | 2.9% |
| Muenchener Rueck | 2.6% |
| Repsol | 2.6% |
No asset data available.
| Date | 07-Dec-2018 |
|---|---|
| NAV | 16.76p |
| Currency | GBP |
| Change | -0.65p |
| % | -3.75% |
| YTD change | 16.76p |
| YTD % | n/a |
| Fund Inception | 01/02/2008 |
|---|---|
| Fund Manager | n/a |
| TER | 0.92 (31-Jan-2014) |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 1.25% |
| Annual Mang't | 0.75% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research